InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,235.48
(
-0.60%
)
US TECH 100
18,030.00
(
-1.25%
)
Dow Jones
38,111.48
(
-0.86%
)
Brent Oil
81.94
(
-1.73%
)
Bitcoin
68,415.46
(
1.23%
)
Post# of 402948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

kfcyahoo

Send PM Follow Ignore
Followers 14
Posts 2297
Boards Moderated 0
Alias Born 12/20/2012

kfcyahoo

Re: djs7 post# 219275

Wednesday, 02/28/2018 2:00:21 PM

Wednesday, February 28, 2018 2:00:21 PM

Post# of 402948
Evidently a phase 1 study: Brief Summary:
The purpose of the phase 1, GTO-003 clinical study is to determine the safety, tolerability and pharmacokinetics of a single dose of a new drug called GC4711 when given as an oral tablet. This study will compare capsules containing a liquid suspension of GC4711 when given orally to a similar drug called GC4419 which will be given as an intravenous infusion. This study will also assess the effect of food on GC4711.

https://clinicaltrials.gov/ct2/show/NCT03099824?term=gc4419&draw=2&rank=7
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent IPIX News
More IPIX News
InvestorsHub NewsWire

FEATURED Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • May 30, 2024 1:18 PM

Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM

ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM

North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM

One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM

Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!